Ain Rahat Ul, Rahman Ali Abdur, Tariq Asfand, Faizan Mahwish
Rahat Ul Ain, MBBS, FCPS (Pediatric Medicine), FCPS (Pediatric Hematology/Oncology) Assistant Professor, Department of Pediatric, Hematology-Oncology and Bone Marrow Transplant, University of Child Health Sciences, The Children's Hospital, Ferozepur Road, Lahore, Pakistan.
Ali Abdur Rahman, MBBS Postgraduate resident in Pediatric Medicine, Shaikh Zayed Hospital Lahore, Lahore, Pakistan.
Pak J Med Sci. 2025 May;41(5):1267-1273. doi: 10.12669/pjms.41.5.9663.
BACKGROUND & OBJECTIVES: Pediatric cancers have a huge survival gap between the high-income and the low-middle-income countries (LMICs). Despite various other causes, the advanced stage of presentation is a major contributing factor but limited data is available from developing countries in this regard. This study aimed to identify delay in treatment and factors associated with it in our setup.
This was a Cross-Sectional survey conducted at the department of pediatric hematology-oncology Children Hospital Lahore using a questionnaire-based interview of parents of all newly diagnosed cases of pediatric cancers presenting to Pakistan's largest public-sector specialized center at the Children's Hospital Lahore, over two months, i.e. from December 1, 2023 to January 31, 2024. The data was analyzed using SPSS version 23.0.
A total of 119 new patients presenting to the hospital were included. The median total delay in treatment of children with cancer was 63 days which is less than comparable LMICs, but physician and healthcare system delay that makes up the major portion of the total delay is equivalent to some low-income countries. The patient delay was negligible. The statistically significant factors associated with delay were gender, age of the patient; and type of cancer. Whereas, the distance from the specialized center and the socio-economic status of the family did not contribute significantly.
Healthcare system delay is a major contributor therefore strengthening the existing medical services, development of medical referral systems, and medical professional awareness and education can improve delays in treatment and outcomes in our setup.
高收入国家与中低收入国家(LMICs)的儿童癌症患者生存率存在巨大差距。尽管有多种其他原因,但就诊时处于晚期是一个主要促成因素,不过在这方面来自发展中国家的数据有限。本研究旨在确定我们机构中治疗延迟情况及其相关因素。
这是一项横断面调查,于拉合尔儿童医院儿科血液肿瘤学部门进行,通过对所有新诊断的儿童癌症病例的家长进行问卷调查式访谈,调查时间为两个月,即2023年12月1日至2024年1月31日。研究对象为前往巴基斯坦最大的公共部门专科医院拉合尔儿童医院就诊的所有新诊断儿童癌症病例。使用SPSS 23.0版本对数据进行分析。
共纳入119名到该院就诊的新患者。癌症患儿治疗的总延迟中位数为63天,这低于可比的中低收入国家,但构成总延迟主要部分的医生和医疗系统延迟与一些低收入国家相当。患者延迟可忽略不计。与延迟相关的具有统计学意义的因素为性别、患者年龄和癌症类型。而距专科医院的距离和家庭社会经济状况对延迟的影响不显著。
医疗系统延迟是主要促成因素,因此加强现有医疗服务、发展医疗转诊系统以及提高医疗专业人员的意识和教育水平可改善我们机构中的治疗延迟情况及治疗效果。